Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 63
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for EXEL

Stock Name	Exelixis Inc
Ticker	EXEL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US30161Q1040

Show aggregate EXEL holdings

News associated with EXEL

Exelixis Reaches Analyst Target Price: In recent trading, shares of Exelixis Inc (Symbol: EXEL) have crossed above the average analyst 12-month target price of $37.15, changing hands for $37.21/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati - 2025-04-25 11:00:40
Barclays PLC Increases Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL): Barclays PLC grew its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 8.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 348,009 shares of the biotechnology company’s stock after buying an additional 28,420 shares during the period. Barclays PLC […] - 2025-04-22 08:47:07
Exelixis, Inc. (NASDAQ:EXEL) Receives $37.59 Average Target Price from Brokerages: Shares of Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the twenty brokerages that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, six have issued a hold rating and twelve have given a buy rating to the company. […] - 2025-04-18 05:28:59
Bank of Montreal Can Has $3.13 Million Stock Position in Exelixis, Inc. (NASDAQ:EXEL): Bank of Montreal Can cut its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 10.0% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 93,921 shares of the biotechnology company’s stock after selling 10,464 shares during the quarter. Bank of Montreal Can’s holdings in Exelixis were worth $3,128,000 as of its most recent […] - 2025-04-16 08:31:00
Fmr LLC Has $98.16 Million Holdings in Exelixis, Inc. (NASDAQ:EXEL): Fmr LLC lifted its stake in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 19.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,947,599 shares of the biotechnology company’s stock after buying an additional 485,527 shares during the quarter. Fmr […] - 2025-04-16 07:34:56
Cerity Partners LLC Buys 45,890 Shares of Exelixis, Inc. (NASDAQ:EXEL): Cerity Partners LLC grew its stake in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 163.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 73,884 shares of the biotechnology company’s stock after acquiring an additional 45,890 shares during the quarter. Cerity Partners LLC’s […] - 2025-04-16 07:34:54
LPL Financial LLC Acquires 22,370 Shares of Exelixis, Inc. (NASDAQ:EXEL): LPL Financial LLC lifted its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 26.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 107,212 shares of the biotechnology company’s stock after acquiring an additional 22,370 shares during the quarter. LPL Financial LLC’s […] - 2025-04-11 07:50:51
Alliancebernstein L.P. Sells 14,245 Shares of Exelixis, Inc. (NASDAQ:EXEL): Alliancebernstein L.P. lessened its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 3.5% during the fourth quarter, HoldingsChannel reports. The firm owned 390,775 shares of the biotechnology company’s stock after selling 14,245 shares during the period. Alliancebernstein L.P.’s holdings in Exelixis were worth $13,013,000 as of its most recent filing with the Securities and […] - 2025-04-10 08:28:58
Exelixis, Inc. (NASDAQ:EXEL) Shares Sold by JPMorgan Chase & Co.: JPMorgan Chase & Co. lowered its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 25.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,314,575 shares of the biotechnology company’s stock after selling 1,116,078 shares during the quarter. JPMorgan Chase […] - 2025-04-03 09:09:17
American Century Companies Inc. Sells 47,750 Shares of Exelixis, Inc. (NASDAQ:EXEL): American Century Companies Inc. cut its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 10.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 415,865 shares of the biotechnology company’s stock after selling 47,750 shares during the quarter. American Century Companies […] - 2025-04-02 08:24:55
Mitsubishi UFJ Trust & Banking Corp Reduces Stock Position in Exelixis, Inc. (NASDAQ:EXEL): Mitsubishi UFJ Trust & Banking Corp trimmed its holdings in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 3.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned 92,009 shares of the biotechnology company’s stock after selling 3,657 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp’s holdings in Exelixis were worth $3,064,000 […] - 2025-04-01 07:58:53
Thrivent Financial for Lutherans Reduces Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL): Thrivent Financial for Lutherans reduced its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 1.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 74,233 shares of the biotechnology company’s stock after selling 1,451 shares during the quarter. Thrivent Financial for Lutherans’ holdings in […] - 2025-03-28 08:28:50
Corient Private Wealth LLC Has $1.52 Million Position in Exelixis, Inc. (NASDAQ:EXEL): Corient Private Wealth LLC raised its stake in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 111.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 45,799 shares of the biotechnology company’s stock after acquiring an additional 24,108 shares during the quarter. Corient Private […] - 2025-03-26 08:40:47
Exelixis, Inc. (NASDAQ:EXEL) Receives Consensus Rating of “Moderate Buy” from Brokerages: Shares of Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty analysts that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and eleven have assigned a buy recommendation to […] - 2025-03-26 06:57:00
Natixis Advisors LLC Buys 31,737 Shares of Exelixis, Inc. (NASDAQ:EXEL): Natixis Advisors LLC grew its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 109.0% in the fourth quarter, Holdings Channel reports. The fund owned 60,850 shares of the biotechnology company’s stock after acquiring an additional 31,737 shares during the quarter. Natixis Advisors LLC’s holdings in Exelixis were worth $2,026,000 at the end of the […] - 2025-03-25 07:56:50
Exelixis, Inc. (NASDAQ:EXEL) Stake Trimmed by Commonwealth Equity Services LLC: Commonwealth Equity Services LLC cut its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 1.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 139,217 shares of the biotechnology company’s stock after selling 2,044 shares during the quarter. Commonwealth Equity Services […] - 2025-03-24 07:57:06
SCHA, ITCI, AFRM, EXEL: Large Outflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab US Small-Cap ETF (Symbol: SCHA) where we have detected an approximate $550.8 million dollar outflow -- that's a 3.3% decrease week over week - 2025-03-17 14:52:32
Zurcher Kantonalbank Zurich Cantonalbank Increases Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL): Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 5.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 63,447 shares of the biotechnology company’s stock after purchasing an additional 3,349 shares during the quarter. Zurcher Kantonalbank […] - 2025-03-17 08:18:58
Exelixis Reaches Analyst Target Price: In recent trading, shares of Exelixis Inc (Symbol: EXEL) have crossed above the average analyst 12-month target price of $37.05, changing hands for $37.18/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati - 2025-03-13 11:00:04
Oppenheimer & Co. Inc. Takes $561,000 Position in Exelixis, Inc. (NASDAQ:EXEL): Oppenheimer & Co. Inc. acquired a new stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 16,836 shares of the biotechnology company’s stock, valued at approximately $561,000. Other hedge funds also recently modified their holdings of the […] - 2025-03-07 09:07:09
Exelixis, Inc. (NASDAQ:EXEL) Shares Bought by Truist Financial Corp: Truist Financial Corp grew its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 31.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 18,169 shares of the biotechnology company’s stock after purchasing an additional 4,378 shares during the quarter. Truist Financial Corp’s […] - 2025-03-03 08:20:57
New York State Common Retirement Fund Trims Holdings in Exelixis, Inc. (NASDAQ:EXEL): New York State Common Retirement Fund reduced its stake in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 10.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 157,257 shares of the biotechnology company’s stock after selling 18,460 shares during the quarter. New York […] - 2025-02-28 09:04:55
Analysts Set Exelixis, Inc. (NASDAQ:EXEL) Price Target at $37.24: Shares of Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the twenty analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, eight have given a hold rating and eleven have given a buy rating to the […] - 2025-02-27 06:22:51
CIBC Asset Management Inc Has $307,000 Stake in Exelixis, Inc. (NASDAQ:EXEL): CIBC Asset Management Inc boosted its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 5.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,210 shares of the biotechnology company’s stock after purchasing an additional 452 shares during the […] - 2025-02-25 08:42:59
Principal Financial Group Inc. Has $22.06 Million Stake in Exelixis, Inc. (NASDAQ:EXEL): Principal Financial Group Inc. reduced its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 0.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 662,436 shares of the biotechnology company’s stock after selling 3,306 shares during the period. Principal Financial […] - 2025-02-24 08:49:13
Exelixis, Inc. (NASDAQ:EXEL) Shares Sold by Rhumbline Advisers: Rhumbline Advisers lessened its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 0.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 827,114 shares of the biotechnology company’s stock after selling 5,657 shares during the period. Rhumbline Advisers’ holdings in Exelixis were worth […] - 2025-02-20 08:54:51
Blue Trust Inc. Purchases 5,137 Shares of Exelixis, Inc. (NASDAQ:EXEL): Blue Trust Inc. grew its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 84.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 11,231 shares of the biotechnology company’s stock after acquiring an additional 5,137 shares during the quarter. Blue Trust Inc.’s holdings in Exelixis […] - 2025-02-19 10:12:49
Short Interest in Exelixis, Inc. (NASDAQ:EXEL) Declines By 9.5%: Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) saw a large decline in short interest in January. As of January 31st, there was short interest totalling 13,090,000 shares, a decline of 9.5% from the January 15th total of 14,460,000 shares. Approximately 4.7% of the shares of the stock are short sold. Based on an average daily […] - 2025-02-19 06:31:00
Exelixis, Inc. (NASDAQ:EXEL) Shares Acquired by V Square Quantitative Management LLC: V Square Quantitative Management LLC increased its stake in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 37.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,563 shares of the biotechnology company’s stock after buying an additional 425 […] - 2025-02-18 09:29:07
Van ECK Associates Corp Buys 78,740 Shares of Exelixis, Inc. (NASDAQ:EXEL): Van ECK Associates Corp lifted its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 45.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 252,324 shares of the biotechnology company’s stock after purchasing an additional 78,740 shares during the period. Van ECK Associates […] - 2025-02-17 08:52:26

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) EXEL holdings

Date	Number of EXEL Shares Held	Base Market Value of EXEL Shares	Local Market Value of EXEL Shares	Change in EXEL Shares Held	Change in EXEL Base Value	Current Price per EXEL Share Held	Previous Price per EXEL Share Held
2025-05-08 (Thursday)	133,230	USD 4,862,895	USD 4,862,895	0	USD -41,301	USD 36.5	USD 36.81
2025-05-07 (Wednesday)	133,230	USD 4,904,196	USD 4,904,196	0	USD -6,662	USD 36.81	USD 36.86
2025-05-06 (Tuesday)	133,230	USD 4,910,858	USD 4,910,858	0	USD -397,025	USD 36.86	USD 39.84
2025-05-05 (Monday)	133,230	USD 5,307,883	USD 5,307,883	0	USD 31,975	USD 39.84	USD 39.6
2025-05-02 (Friday)	133,230	USD 5,275,908	USD 5,275,908	0	USD 94,593	USD 39.6	USD 38.89
2025-05-01 (Thursday)	133,230	USD 5,181,315	USD 5,181,315	0	USD -34,640	USD 38.89	USD 39.15
2025-04-30 (Wednesday)	133,230	USD 5,215,955	USD 5,215,955	0	USD 79,938	USD 39.15	USD 38.55
2025-04-29 (Tuesday)	133,230	USD 5,136,017	USD 5,136,017	0	USD 14,656	USD 38.55	USD 38.44
2025-04-28 (Monday)	133,230	USD 5,121,361	USD 5,121,361	0	USD 134,562	USD 38.44	USD 37.43
2025-04-25 (Friday)	133,230	USD 4,986,799	USD 4,986,799	0	USD 29,311	USD 37.43	USD 37.21
2025-04-24 (Thursday)	133,230	USD 4,957,488	USD 4,957,488	0	USD 57,289	USD 37.21	USD 36.78
2025-04-23 (Wednesday)	133,230	USD 4,900,199	USD 4,900,199	465	USD 56,932	USD 36.78	USD 36.48
2025-04-22 (Tuesday)	132,765	USD 4,843,267	USD 4,843,267	0	USD 118,161	USD 36.48	USD 35.59
2025-04-21 (Monday)	132,765	USD 4,725,106	USD 4,725,106	0	USD -79,659	USD 35.59	USD 36.19
2025-04-18 (Friday)	132,765	USD 4,804,765	USD 4,804,765	0	USD 0	USD 36.19	USD 36.19
2025-04-17 (Thursday)	132,765	USD 4,804,765	USD 4,804,765	0	USD 5,310	USD 36.19	USD 36.15
2025-04-16 (Wednesday)	132,765	USD 4,799,455	USD 4,799,455	0	USD -51,778	USD 36.15	USD 36.54
2025-04-15 (Tuesday)	132,765	USD 4,851,233	USD 4,851,233	0	USD 106,212	USD 36.54	USD 35.74
2025-04-14 (Monday)	132,765	USD 4,745,021	USD 4,745,021	0	USD 57,089	USD 35.74	USD 35.31
2025-04-11 (Friday)	132,765	USD 4,687,932	USD 4,687,932	0	USD 112,850	USD 35.31	USD 34.46
2025-04-10 (Thursday)	132,765	USD 4,575,082	USD 4,575,082	-3,720	USD -248,298	USD 34.46	USD 35.34
2025-04-09 (Wednesday)	136,485	USD 4,823,380	USD 4,823,380	0	USD 165,147	USD 35.34	USD 34.13
2025-04-08 (Tuesday)	136,485	USD 4,658,233	USD 4,658,233	-465	USD -113,105	USD 34.13	USD 34.84
2025-04-07 (Monday)	136,950	USD 4,771,338	USD 4,771,338	-465	USD 20,901	USD 34.84	USD 34.57
2025-04-04 (Friday)	137,415	USD 4,750,437	USD 4,750,437	-2,325	USD -425,533	USD 34.57	USD 37.04
2025-04-02 (Wednesday)	139,740	USD 5,175,970	USD 5,175,970	0	USD 90,831	USD 37.04	USD 36.39
2025-04-01 (Tuesday)	139,740	USD 5,085,139	USD 5,085,139	4,029	USD 74,689	USD 36.39	USD 36.92
2025-03-31 (Monday)	135,711	USD 5,010,450	USD 5,010,450	-1,374	USD -20,570	USD 36.92	USD 36.7
2025-03-28 (Friday)	137,085	USD 5,031,020	USD 5,031,020	0	USD -19,191	USD 36.7	USD 36.84
2025-03-27 (Thursday)	137,085	USD 5,050,211	USD 5,050,211	0	USD -23,305	USD 36.84	USD 37.01
2025-03-26 (Wednesday)	137,085	USD 5,073,516	USD 5,073,516	0	USD -95,959	USD 37.01	USD 37.71
2025-03-25 (Tuesday)	137,085	USD 5,169,475	USD 5,169,475	0	USD -1,371	USD 37.71	USD 37.72
2025-03-24 (Monday)	137,085	USD 5,170,846	USD 5,170,846	0	USD 104,184	USD 37.72	USD 36.96
2025-03-21 (Friday)	137,085	USD 5,066,662	USD 5,066,662	2,619	USD 67,216	USD 36.96	USD 37.18
2025-03-20 (Thursday)	134,466	USD 4,999,446	USD 4,999,446	0	USD 16,136	USD 37.18	USD 37.06
2025-03-19 (Wednesday)	134,466	USD 4,983,310	USD 4,983,310	0	USD 94,126	USD 37.06	USD 36.36
2025-03-18 (Tuesday)	134,466	USD 4,889,184	USD 4,889,184	0	USD -88,747	USD 36.36	USD 37.02
2025-03-17 (Monday)	134,466	USD 4,977,931	USD 4,977,931	0	USD 49,752	USD 37.02	USD 36.65
2025-03-14 (Friday)	134,466	USD 4,928,179	USD 4,928,179	-7,184	USD -284,541	USD 36.65	USD 36.8
2025-03-13 (Thursday)	141,650	USD 5,212,720	USD 5,212,720	0	USD -56,660	USD 36.8	USD 37.2
2025-03-12 (Wednesday)	141,650	USD 5,269,380	USD 5,269,380	0	USD 38,245	USD 37.2	USD 36.93
2025-03-11 (Tuesday)	141,650	USD 5,231,135	USD 5,231,135	0	USD -315,171	USD 36.93	USD 39.155
2025-03-10 (Monday)	141,650	USD 5,546,306	USD 5,546,306	0	USD 81,449	USD 39.155	USD 38.58
2025-03-07 (Friday)	141,650	USD 5,464,857	USD 5,464,857	-898	USD 18,098	USD 38.58	USD 38.21
2025-03-06 (Thursday)	142,548	USD 5,446,759	USD 5,446,759	0	USD -62,721	USD 38.21	USD 38.65
2025-03-05 (Wednesday)	142,548	USD 5,509,480	USD 5,509,480	0	USD 51,317	USD 38.65	USD 38.29
2025-03-04 (Tuesday)	142,548	USD 5,458,163	USD 5,458,163	-449	USD -54,371	USD 38.29	USD 38.55
2025-03-03 (Monday)	142,997	USD 5,512,534	USD 5,512,534	0	USD -20,020	USD 38.55	USD 38.69
2025-02-28 (Friday)	142,997	USD 5,532,554	USD 5,532,554	0	USD 148,717	USD 38.69	USD 37.65
2025-02-27 (Thursday)	142,997	USD 5,383,837	USD 5,383,837	0	USD 17,160	USD 37.65	USD 37.53
2025-02-26 (Wednesday)	142,997	USD 5,366,677	USD 5,366,677	0	USD 87,228	USD 37.53	USD 36.92
2025-02-25 (Tuesday)	142,997	USD 5,279,449	USD 5,279,449	898	USD 3,313	USD 36.92	USD 37.13
2025-02-24 (Monday)	142,099	USD 5,276,136	USD 5,276,136	0	USD 39,788	USD 37.13	USD 36.85
2025-02-21 (Friday)	142,099	USD 5,236,348	USD 5,236,348	0	USD 250,094	USD 36.85	USD 35.09
2025-02-20 (Thursday)	142,099	USD 4,986,254	USD 4,986,254	0	USD 2,842	USD 35.09	USD 35.07
2025-02-19 (Wednesday)	142,099	USD 4,983,412	USD 4,983,412	-449	USD 108,270	USD 35.07	USD 34.2
2025-02-18 (Tuesday)	142,548	USD 4,875,142	USD 4,875,142	0	USD -114,038	USD 34.2	USD 35
2025-02-17 (Monday)	142,548	USD 4,989,180	USD 4,989,180	0	USD 0	USD 35	USD 35
2025-02-14 (Friday)	142,548	USD 4,989,180	USD 4,989,180	0	USD 72,699	USD 35	USD 34.49
2025-02-13 (Thursday)	142,548	USD 4,916,481	USD 4,916,481	1,347	USD 285,088	USD 34.49	USD 32.8
2025-02-12 (Wednesday)	141,201	USD 4,631,393	USD 4,631,393	449	USD 13,320	USD 32.8	USD 32.81
2025-02-11 (Tuesday)	140,752	USD 4,618,073	USD 4,618,073	1,796	USD -36,953	USD 32.81	USD 33.5
2025-02-10 (Monday)	138,956	USD 4,655,026	USD 4,655,026	0	USD 2,779	USD 33.5	USD 33.48
2025-02-07 (Friday)	138,956	USD 4,652,247	USD 4,652,247	0	USD -26,402	USD 33.48	USD 33.67
2025-02-06 (Thursday)	138,956	USD 4,678,649	USD 4,678,649	0	USD 16,675	USD 33.67	USD 33.55
2025-02-05 (Wednesday)	138,956	USD 4,661,974	USD 4,661,974	0	USD 59,751	USD 33.55	USD 33.12
2025-02-04 (Tuesday)	138,956	USD 4,602,223	USD 4,602,223	0	USD 33,350	USD 33.12	USD 32.88
2025-02-03 (Monday)	138,956	USD 4,568,873	USD 4,568,873	0	USD -37,518	USD 32.88	USD 33.15
2025-01-31 (Friday)	138,956	USD 4,606,391	USD 4,606,391	0	USD 30,570	USD 33.15	USD 32.93
2025-01-30 (Thursday)	138,956	USD 4,575,821	USD 4,575,821	0	USD -4,169	USD 32.93	USD 32.96
2025-01-29 (Wednesday)	138,956	USD 4,579,990	USD 4,579,990	0	USD 50,024	USD 32.96	USD 32.6
2025-01-28 (Tuesday)	138,956	USD 4,529,966	USD 4,529,966	0	USD -18,064	USD 32.6	USD 32.73
2025-01-27 (Monday)	138,956	USD 4,548,030	USD 4,548,030	0	USD 48,635	USD 32.73	USD 32.38
2025-01-24 (Friday)	138,956	USD 4,499,395	USD 4,499,395	0	USD -243,173	USD 32.38	USD 34.13
2025-01-23 (Thursday)	138,956	USD 4,742,568	USD 4,742,568	0	USD 173,695	USD 34.13	USD 32.88
2025-01-22 (Wednesday)	138,956	USD 4,568,873	USD 4,568,873
2025-01-21 (Tuesday)	138,956	USD 5,062,167	USD 5,062,167
2025-01-20 (Monday)	138,956	USD 5,030,207	USD 5,030,207
2025-01-17 (Friday)	138,956	USD 5,030,207	USD 5,030,207
2025-01-16 (Thursday)	137,160	USD 5,013,198	USD 5,013,198
2025-01-15 (Wednesday)	135,364	USD 5,045,016	USD 5,045,016
2025-01-14 (Tuesday)	135,364	USD 4,825,727	USD 4,825,727
2025-01-13 (Monday)	135,364	USD 4,778,349	USD 4,778,349
2025-01-10 (Friday)	135,364	USD 4,875,811	USD 4,875,811
2025-01-09 (Thursday)	136,262	USD 4,701,039	USD 4,701,039
2025-01-09 (Thursday)	136,262	USD 4,701,039	USD 4,701,039
2025-01-09 (Thursday)	136,262	USD 4,701,039	USD 4,701,039
2025-01-08 (Wednesday)	136,262	USD 4,701,039	USD 4,701,039
2025-01-08 (Wednesday)	136,262	USD 4,701,039	USD 4,701,039
2025-01-08 (Wednesday)	136,262	USD 4,701,039	USD 4,701,039
2025-01-02 (Thursday)	138,058	USD 4,685,689	USD 4,685,689	710	USD 57,061	USD 33.94	USD 33.7
2024-12-30 (Monday)	137,348	USD 4,628,628	USD 4,628,628	-15,662	USD -761,914	USD 33.7	USD 35.23
2024-12-10 (Tuesday)	153,010	USD 5,390,542	USD 5,390,542	0	USD 9,180	USD 35.23	USD 35.17
2024-12-09 (Monday)	153,010	USD 5,381,362	USD 5,381,362	0	USD -99,456	USD 35.17	USD 35.82
2024-12-06 (Friday)	153,010	USD 5,480,818	USD 5,480,818	0	USD -33,662	USD 35.82	USD 36.04
2024-12-05 (Thursday)	153,010	USD 5,514,480	USD 5,514,480	0	USD 41,312	USD 36.04	USD 35.77
2024-12-04 (Wednesday)	153,010	USD 5,473,168	USD 5,473,168	0	USD 78,035	USD 35.77	USD 35.26
2024-12-03 (Tuesday)	153,010	USD 5,395,133	USD 5,395,133	0	USD -50,493	USD 35.26	USD 35.59
2024-12-02 (Monday)	153,010	USD 5,445,626	USD 5,445,626	0	USD -133,119	USD 35.59	USD 36.46
2024-11-29 (Friday)	153,010	USD 5,578,745	USD 5,578,745	0	USD 81,096	USD 36.46	USD 35.93
2024-11-28 (Thursday)	153,010	USD 5,497,649	USD 5,497,649	0	USD 0	USD 35.93	USD 35.93
2024-11-27 (Wednesday)	153,010	USD 5,497,649	USD 5,497,649	0	USD -79,566	USD 35.93	USD 36.45
2024-11-26 (Tuesday)	153,010	USD 5,577,215	USD 5,577,215	0	USD 10,711	USD 36.45	USD 36.38
2024-11-25 (Monday)	153,010	USD 5,566,504	USD 5,566,504	0	USD 117,818	USD 36.38	USD 35.61
2024-11-22 (Friday)	153,010	USD 5,448,686	USD 5,448,686	0	USD 119,348	USD 35.61	USD 34.83
2024-11-21 (Thursday)	153,010	USD 5,329,338	USD 5,329,338	0	USD 27,541	USD 34.83	USD 34.65
2024-11-20 (Wednesday)	153,010	USD 5,301,797	USD 5,301,797	0	USD 36,723	USD 34.65	USD 34.41
2024-11-19 (Tuesday)	153,010	USD 5,265,074	USD 5,265,074	0	USD -16,831	USD 34.41	USD 34.52
2024-11-18 (Monday)	153,010	USD 5,281,905	USD 5,281,905	-7,335	USD -466,463	USD 34.52	USD 35.85
2024-11-12 (Tuesday)	160,345	USD 5,748,368	USD 5,748,368	0	USD -64,138	USD 35.85	USD 36.25
2024-11-08 (Friday)	160,345	USD 5,812,506	USD 5,812,506	-489	USD 54,649	USD 36.25	USD 35.8
2024-11-07 (Thursday)	160,834	USD 5,757,857	USD 5,757,857	0	USD 46,642	USD 35.8	USD 35.51
2024-11-06 (Wednesday)	160,834	USD 5,711,215	USD 5,711,215	0	USD 119,017	USD 35.51	USD 34.77
2024-11-05 (Tuesday)	160,834	USD 5,592,198	USD 5,592,198	0	USD 77,200	USD 34.77	USD 34.29
2024-11-04 (Monday)	160,834	USD 5,514,998	USD 5,514,998	0	USD 27,342	USD 34.29	USD 34.12
2024-11-01 (Friday)	160,834	USD 5,487,656	USD 5,487,656	0	USD 147,967	USD 34.12	USD 33.2
2024-10-31 (Thursday)	160,834	USD 5,339,689	USD 5,339,689	0	USD 122,234	USD 33.2	USD 32.44
2024-10-30 (Wednesday)	160,834	USD 5,217,455	USD 5,217,455	0	USD 596,694	USD 32.44	USD 28.73
2024-10-29 (Tuesday)	160,834	USD 4,620,761	USD 4,620,761	0	USD 36,992	USD 28.73	USD 28.5
2024-10-28 (Monday)	160,834	USD 4,583,769	USD 4,583,769	0	USD 101,325	USD 28.5	USD 27.87
2024-10-25 (Friday)	160,834	USD 4,482,444	USD 4,482,444	0	USD -38,600	USD 27.87	USD 28.11
2024-10-24 (Thursday)	160,834	USD 4,521,044	USD 4,521,044	0	USD -33,775	USD 28.11	USD 28.32
2024-10-23 (Wednesday)	160,834	USD 4,554,819	USD 4,554,819	0	USD -82,025	USD 28.32	USD 28.83
2024-10-22 (Tuesday)	160,834	USD 4,636,844	USD 4,636,844	0	USD 27,342	USD 28.83	USD 28.66
2024-10-21 (Monday)	160,834	USD 4,609,502	USD 4,609,502	-490	USD -52,762	USD 28.66	USD 28.9
2024-10-18 (Friday)	161,324	USD 4,662,264	USD 4,662,264

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EXEL by Blackrock for IE00BDZVHG35

Show aggregate share trades of EXEL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-04-23 BUY 465 36.780* 35.05
2025-04-10 SELL -3,720 34.460* 34.97 Profit of 130,077 on sale
2025-04-08 SELL -465 34.130* 34.97 Profit of 16,262 on sale
2025-04-07 SELL -465 34.840* 34.97 Profit of 16,263 on sale
2025-04-04 SELL -2,325 34.570* 34.98 Profit of 81,325 on sale
2025-04-01 BUY 4,029 36.390* 34.94
2025-03-31 SELL -1,374 36.920* 34.91 Profit of 47,970 on sale
2025-03-21 BUY 2,619 36.960* 34.74
2025-03-14 SELL -7,184 36.650* 34.59 Profit of 248,467 on sale
2025-03-07 SELL -898 38.580* 34.35 Profit of 30,844 on sale
2025-03-04 SELL -449 38.290* 34.16 Profit of 15,336 on sale
2025-02-25 BUY 898 36.920* 33.84
2025-02-19 SELL -449 35.070* 33.67 Profit of 15,119 on sale
2025-02-13 BUY 1,347 34.490* 33.59
2025-02-12 BUY 449 32.800* 33.61
2025-02-11 BUY 1,796 32.810* 33.63
2025-01-02 BUY 710 33.940* 33.79
2024-12-30 SELL -15,662 33.700* 33.80 Profit of 529,328 on sale
2024-11-18 SELL -7,335 34.520* 31.95 Profit of 234,376 on sale
2024-11-08 SELL -489 36.250* 31.37 Profit of 15,339 on sale
2024-10-21 SELL -490 28.660* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-04-23	BUY	465	36.780*	35.05
2025-04-10	SELL	-3,720	34.460*	34.97 Profit of 130,077 on sale
2025-04-08	SELL	-465	34.130*	34.97 Profit of 16,262 on sale
2025-04-07	SELL	-465	34.840*	34.97 Profit of 16,263 on sale
2025-04-04	SELL	-2,325	34.570*	34.98 Profit of 81,325 on sale
2025-04-01	BUY	4,029	36.390*	34.94
2025-03-31	SELL	-1,374	36.920*	34.91 Profit of 47,970 on sale
2025-03-21	BUY	2,619	36.960*	34.74
2025-03-14	SELL	-7,184	36.650*	34.59 Profit of 248,467 on sale
2025-03-07	SELL	-898	38.580*	34.35 Profit of 30,844 on sale
2025-03-04	SELL	-449	38.290*	34.16 Profit of 15,336 on sale
2025-02-25	BUY	898	36.920*	33.84
2025-02-19	SELL	-449	35.070*	33.67 Profit of 15,119 on sale
2025-02-13	BUY	1,347	34.490*	33.59
2025-02-12	BUY	449	32.800*	33.61
2025-02-11	BUY	1,796	32.810*	33.63
2025-01-02	BUY	710	33.940*	33.79
2024-12-30	SELL	-15,662	33.700*	33.80 Profit of 529,328 on sale
2024-11-18	SELL	-7,335	34.520*	31.95 Profit of 234,376 on sale
2024-11-08	SELL	-489	36.250*	31.37 Profit of 15,339 on sale
2024-10-21	SELL	-490	28.660*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EXEL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-05-09	409,190	0	675,573	60.6%
2025-05-08	608,680	1,217	1,439,867	42.3%
2025-05-07	501,068	1,300	1,013,367	49.4%
2025-05-06	899,548	1,748	1,376,238	65.4%
2025-05-05	533,493	5,366	759,304	70.3%
2025-05-02	464,422	2,308	703,821	66.0%
2025-05-01	417,490	16,088	684,970	61.0%
2025-04-30	347,150	1	611,036	56.8%
2025-04-29	339,066	1,133	542,600	62.5%
2025-04-28	630,315	0	863,288	73.0%
2025-04-25	272,594	0	460,178	59.2%
2025-04-24	453,754	5,221	608,587	74.6%
2025-04-23	802,910	1,000	1,108,166	72.5%
2025-04-22	326,447	4,539	647,819	50.4%
2025-04-21	389,790	566	666,961	58.4%
2025-04-17	600,249	575	848,222	70.8%
2025-04-16	803,729	1,615	1,049,483	76.6%
2025-04-15	754,693	2,839	886,999	85.1%
2025-04-14	455,794	4,853	659,674	69.1%
2025-04-11	495,348	100	691,312	71.7%
2025-04-10	760,959	36	1,042,369	73.0%
2025-04-09	1,231,010	682	1,826,217	67.4%
2025-04-08	650,519	27	892,379	72.9%
2025-04-07	690,019	344	1,030,737	66.9%
2025-04-04	686,465	711	1,059,538	64.8%
2025-04-03	453,027	76	746,442	60.7%
2025-04-02	434,980	242	634,442	68.6%
2025-04-01	720,713	98	1,054,150	68.4%
2025-03-31	677,838	1,173	909,658	74.5%
2025-03-28	279,319	0	409,170	68.3%
2025-03-27	416,931	0	933,468	44.7%
2025-03-26	699,556	2	841,064	83.2%
2025-03-25	799,772	25	999,091	80.0%
2025-03-24	396,759	1,308	562,146	70.6%
2025-03-21	643,718	0	949,070	67.8%
2025-03-20	551,198	1,500	906,307	60.8%
2025-03-19	247,459	0	603,329	41.0%
2025-03-18	308,595	1,132	580,810	53.1%
2025-03-17	347,246	7,994	709,923	48.9%
2025-03-14	385,168	340	706,564	54.5%
2025-03-13	318,401	129	785,483	40.5%
2025-03-12	576,327	176	963,324	59.8%
2025-03-11	460,061	3,937	1,178,100	39.1%
2025-03-10	937,773	515	1,456,762	64.4%
2025-03-07	486,400	501	681,444	71.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE